Image-Based Consensus Molecular Subtyping in Rectal Cancer Biopsies and Response to Neoadjuvant Chemoradiotherapy
Maxime W Lafarge, Enric Domingo, Korsuk Sirinukunwattana, Ruby Wood, Leslie Samuel, Graeme Murray, Susan D Richman, Andrew Blake, David Sebag-Montefiore, Simon Gollins, Eckhard Klieser, Daniel Neureiter, Florian Huemer, Richard Greil, Philip Dunne, Philip Quirke, Lukas Weiss, Jens Rittscher, Tim Maughan, Viktor H Koelzer
doi: https://doi.org/10.1101/2023.10.26.23297521
Maxime W Lafarge
1Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
Enric Domingo
2Department of Oncology, Medical Sciences Division, University of Oxford, Oxford, UK
Korsuk Sirinukunwattana
3Ground Truth Labs, Oxford, UK
4Department of Engineering Science, Institute of Biomedical Engineering (IBME), University of Oxford, Oxford, UK
Ruby Wood
5Department of Engineering Science, University of Oxford, Oxford, UK
Leslie Samuel
6School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK
Graeme Murray
6School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK
Susan D Richman
7Leeds Institute of Medical Research, University of Leeds, Leeds, UK
Andrew Blake
2Department of Oncology, Medical Sciences Division, University of Oxford, Oxford, UK
David Sebag-Montefiore
7Leeds Institute of Medical Research, University of Leeds, Leeds, UK
Simon Gollins
8North Wales Cancer Treatment Centre, Besti Cadwaladr University Health Board, Bodelwyddan, UK
Eckhard Klieser
9Institute of Pathology, Paracelsus Medical University, Salzburg, Austria
Daniel Neureiter
9Institute of Pathology, Paracelsus Medical University, Salzburg, Austria
Florian Huemer
10Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University Salzburg, Salzburg, Austria
Richard Greil
10Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University Salzburg, Salzburg, Austria
Philip Dunne
11The Patrick G Johnston Centre for Cancer Research, Queens University Belfast, Belfast, UK
Philip Quirke
7Leeds Institute of Medical Research, University of Leeds, Leeds, UK
Lukas Weiss
10Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University Salzburg, Salzburg, Austria
Jens Rittscher
4Department of Engineering Science, Institute of Biomedical Engineering (IBME), University of Oxford, Oxford, UK
12NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Tim Maughan
2Department of Oncology, Medical Sciences Division, University of Oxford, Oxford, UK
Viktor H Koelzer
1Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
13Department of Oncology and Nuffield Department of Medicine, University of Oxford, Oxford, UK
Article usage
Posted October 26, 2023.
Image-Based Consensus Molecular Subtyping in Rectal Cancer Biopsies and Response to Neoadjuvant Chemoradiotherapy
Maxime W Lafarge, Enric Domingo, Korsuk Sirinukunwattana, Ruby Wood, Leslie Samuel, Graeme Murray, Susan D Richman, Andrew Blake, David Sebag-Montefiore, Simon Gollins, Eckhard Klieser, Daniel Neureiter, Florian Huemer, Richard Greil, Philip Dunne, Philip Quirke, Lukas Weiss, Jens Rittscher, Tim Maughan, Viktor H Koelzer
medRxiv 2023.10.26.23297521; doi: https://doi.org/10.1101/2023.10.26.23297521
Image-Based Consensus Molecular Subtyping in Rectal Cancer Biopsies and Response to Neoadjuvant Chemoradiotherapy
Maxime W Lafarge, Enric Domingo, Korsuk Sirinukunwattana, Ruby Wood, Leslie Samuel, Graeme Murray, Susan D Richman, Andrew Blake, David Sebag-Montefiore, Simon Gollins, Eckhard Klieser, Daniel Neureiter, Florian Huemer, Richard Greil, Philip Dunne, Philip Quirke, Lukas Weiss, Jens Rittscher, Tim Maughan, Viktor H Koelzer
medRxiv 2023.10.26.23297521; doi: https://doi.org/10.1101/2023.10.26.23297521
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)